Allelic and genotypic frequencies of <i>NAT2</i> , <i>CYP2E1</i> , and <i>AADAC</i> genes in a cohort of Peruvian tuberculosis patients

Abstract

This high prevalence of slow metabolizers for isoniazid in the Peruvian population should be further studied and considered to help individualize drug regimens, especially in countries with a great genetic diversity like Peru. These data will help the Peruvian National Tuberculosis Control Program develop new strategies for therapies.